{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:20:26Z","timestamp":1770762026212,"version":"3.50.0"},"reference-count":45,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"vor","delay-in-days":1130,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>The objective of this randomized, double\u2010blind, placebo\u2010controlled, dose escalation study was to determine the pharmacokinetic characteristics, safety, and tolerability of single doses of inhaled loxapine aerosol in healthy volunteers. Loxapine was delivered by means of a unique thermally generated aerosol comprising drug particles of a size designed for deep lung delivery and absorption. Fifty participants were randomized to receive 0.625, 1.25, 2.5, 5.0, or 10 mg of loxapine aerosol or placebo. Following inhalation, the t<jats:sub>max<\/jats:sub> median (25%, 75%) was 2 (1, 3) minutes. The loxapine AUC<jats:sub>\u221e<\/jats:sub> was dose proportional across all doses with slope (90% confidence interval) of log AUC<jats:sub>\u221e<\/jats:sub> versus log dose = 0.909 (0.832, 0.987). No clinically meaningful changes were noted in hematology results, blood chemistry, vital signs, or respiratory function. The most common adverse events were dizziness, somnolence, and bad taste. The inhalation of Staccato loxapine represents a safe, well\u2010tolerated means for rapidly achieving therapeutic plasma concentrations of loxapine.<\/jats:p>","DOI":"10.1177\/0091270009347866","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T03:29:07Z","timestamp":1258169347000},"page":"169-179","source":"Crossref","is-referenced-by-count":52,"title":["Pharmacokinetics of Loxapine Following Inhalation of a Thermally Generated Aerosol in Healthy Volunteers"],"prefix":"10.1002","volume":"50","author":[{"given":"Daniel A.","family":"Spyker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Munzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James V.","family":"Cassella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/10673220127892"},{"key":"e_1_2_6_3_2","first-page":"101","article-title":"Diagnosing and managing delirium in the elderly","volume":"47","author":"Conn DK","year":"2001","journal-title":"Can Fam Physician"},{"key":"e_1_2_6_4_2","first-page":"3","article-title":"Treatment of agitation in bipolar disorder across the life cycle","volume":"64","author":"Alderfer BS","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565090-00003"},{"issue":"10","key":"e_1_2_6_6_2","first-page":"52","article-title":"The role of typical and atypical antipsychotic medications in the management of agitation and aggression","volume":"60","author":"Buckley PF.","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_2_6_7_2","first-page":"1","article-title":"The expert consensus guideline series: treatment of behavioral emergencies 2005","volume":"11","author":"Allen MH","year":"2005","journal-title":"J Psychiatr Pract"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216040-00002"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2004.09.001"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200301000-00004"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200301000-00005"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2003.08.002"},{"key":"e_1_2_6_13_2","first-page":"1","article-title":"The Expert Consensus Guideline Series: treatment of behavioral emergencies","author":"Allen MH","year":"2001","journal-title":"Postgrad Med"},{"key":"e_1_2_6_14_2","unstructured":"FDA Alert: Haloperidol 2007 US Food and Drug Administration Center for Drug Evaluation and Research"},{"key":"e_1_2_6_15_2","first-page":"80","article-title":"A double\u2010blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia","volume":"21","author":"Paprocki J","year":"1977","journal-title":"Curr Ther Res Clin Exp"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00226.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(82)73416-4"},{"key":"e_1_2_6_18_2","first-page":"294","article-title":"Rapid tranquilization: a comparison of thiothixene with loxapine","volume":"47","author":"Dubin WR","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_19_2","first-page":"656","article-title":"Interest in injectable loxapine for severe agitation","volume":"69","author":"Gaussares C","year":"1989","journal-title":"Inf Psychiatr"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.062893"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20694"},{"key":"e_1_2_6_22_2","first-page":"29","article-title":"Particle transport onto human airway surfaces","volume":"119","author":"Heyder J.","year":"1982","journal-title":"Eur J Respir Dis Suppl"},{"key":"e_1_2_6_23_2","first-page":"735","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"e_1_2_6_24_2","first-page":"175","article-title":"Clinical pharmacological trial of loxapine succinate","volume":"10","author":"Wolpert A","year":"1970","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_6_25_2","first-page":"126","article-title":"A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients","volume":"47","author":"Tuason VB.","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(99)80048-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2006.05.006"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003495-197815030-00002","article-title":"Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent","volume":"15","author":"Heel RC","year":"1978","journal-title":"Drugs"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199528060-00007"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.1973.tb00801.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/009286159502900324"},{"key":"e_1_2_6_32_2","first-page":"177","article-title":"The role of metabolites in a bioequivalence study 1: loxapine, 7\u2010hydroxyloxapine and 8\u2010hydroxyloxapine","volume":"31","author":"Midha KK","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0303"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0315"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/emj.20.4.339"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.7.1149"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.5.441"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900025487"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544110-00002"},{"key":"e_1_2_6_40_2","volume-title":"ABILIFY (aripiprazole) solution, tablets and injection [prescribing information]","year":"2008"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680224"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431855"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920006779010575"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198308000-00012"},{"key":"e_1_2_6_45_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-4347(91)80083-O","article-title":"Simultaneous quantitation of loxapine, amoxapine and their 7\u2010 and 8\u2010hydroxy metabolites in plasma by high\u2010performance liquid chromatography","volume":"564","author":"Cheung SW","year":"1991","journal-title":"J Chromatogr"},{"key":"e_1_2_6_46_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(79)90396-0","article-title":"3H\u2010Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites","volume":"55","author":"Coupet J","year":"1979","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270009347866","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0091270009347866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T19:51:51Z","timestamp":1698954711000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/0091270009347866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1177\/0091270009347866"],"URL":"https:\/\/doi.org\/10.1177\/0091270009347866","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}